Stocks · News reference
This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Top Wall Street analysts changed outlook on top stocks. See full analyst rating changes & buy/sell recommendations for PBLS stock on Benzinga.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Frequency Electronics, ACV Auctions, HP And Other Big Stocks Moving Higher On Friday
U.S. stocks rose; Frequency Electronics surged 30.7% after beating Q1 estimates, while ACV Auctions jumped 44.3% on Copart’s acquisition deal.
Guggenheim Maintains Buy on ERock, Lowers Price Target to $20
Guggenheim analyst Joseph Osha maintains ERock (NYSE:EROC) with a Buy and lowers the price target from $23 to $20.
'I Don't Know John Ternus,' Jim Cramer Says — but He Trusts Tim Cook's Word on Apple's Next CEO
Jim Cramer recommends buying CSCO, notes its strong quarter. APPL still a good buy with Tim Cook's successor announced. Vale may hedge inflation. ERock not advised, go with CoreWeave. Cisco, Apple, ERock shares up, Vale down.
Forbright Bank To Sell Its Washington, D.C.-Area Legacy Branches And ~$750M In Local Deposits To Trustar Bank For A Deposit Premium Of ~$19M
The Company expects the Transaction to be accretive to 2027 earnings.Shaza Andersen, Chief Executive Officer of Trustar Bank, stated, "We are very pleased to enter into this Agreement with Forbright Bank. I have
Wells Fargo Maintains Overweight on Forbright, Raises Price Target to $22
Wells Fargo analyst Terry McEvoy maintains Forbright (NASDAQ:FRBT) with a Overweight and raises the price target from $21 to $22.